SCHEMBL4480126

SCHEMBL4480126

[B]1OCc2cccn21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208858 0.56
SCHEMBL2405580 0.55
SCHEMBL16467921 0.53
Biphenyl SCHEMBL27498009 0.39 ALDH1A1 (0.82)
Water SCHEMBL27675468 0.37
Naphthalene SCHEMBL1652419 0.35 CYP2A6 (0.89)
SCHEMBL14354393 0.32
Benzene SCHEMBL10953244 0.32 TSHR (0.75)
Benzene SCHEMBL18095087 0.32
Benzene SCHEMBL8992260 0.32 TSHR (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5466880-A Process for preparing ketone enantiomer PFIZER INC. (US) 1995-11-14 US claimed
US-7618987-B2 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK & CO., INC. (US) 2009-11-17 US disclosed
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK SHARP & DOHME CORP. 2007-08-16 US disclosed
US-7192980-B2 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors NOVARTIS AG (CH) 2007-03-20 US disclosed
US-6972292-B2 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors NOVARTIS AG (CH) 2005-12-06 US disclosed
US-20050049249-A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors KINDER FREDERICK R (US) 2005-03-03 US disclosed
US-20030087934-A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors PARALLEL WIRELESS, INC. 2003-05-08 US disclosed
US-6506901-B2 1-(9H-Carbazol-4-yloxy)-3-((1-(7-trifluoromethyl-quinolin-4-yl) -piperidin-4-lmethyl)-amino)-propan-2-ol, for example; treating diabetes, urinary continence, atherosclerosis, gastrointestinal disorders, glaucoma WYETH 2003-01-14 US disclosed
US-20020065312-A1 Aminotetralins as 5-HT1Dalpha agonists SCHAUS JOHN M (US) 2002-05-30 US disclosed
US-20020037907-A1 Substituted 2- (S) -hydroxy-3- (piperidin-4-yl-methylamino) -propyl ethers and substituted 2-aryl-2- (R) - hydroxy-1- (piperidin-4-yl-methyl) -ethylamine beta-3 adrenergic receptor agonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-03-28 US disclosed
US-6355674-B1 PSYCHOLOGICAL DISORDERS; ANTISEROTONINE AGENTS ELI LILLY AND COMPANY 2002-03-12 US disclosed
US-5576442-A Process and chiral intermediates for thiazole antidiabetics PFIZER INC. (US) 1996-11-19 US disclosed
US-5536747-A ENZYME INHIBITORS SYNTEX (U.S.A.) INC. (US) 1996-07-16 US disclosed
US-5466880-A Process for preparing ketone enantiomer PFIZER INC. (US) 1995-11-14 US disclosed
EP-0624152-A1 PROCESS FOR PREPARING KETONE ENANTIOMER. PFIZER (US) 1994-11-17 EP disclosed
WO-1993012062-A1 PROCESS FOR PREPARING KETONE ENANTIOMER PFIZER INC. (US) 1993-06-24 WO disclosed